secwatch.observer — SEC 8-K summary
======================================

Issuer:     Milestone Pharmaceuticals Inc. (MIST)
CIK:        0001408443
Form:       8-K
Filed at:   2025-03-19T23:59:59+00:00
Accession:  0001104659-25-025547
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.08
LLM model:  deepseek-v4-flash:cloud@v2

Milestone Pharmaceuticals sets June 10, 2025 as annual meeting date; record date April 15
--------------------------------------------------------------------------------

- 2025 annual meeting scheduled for June 10, 2025; record date for voting is April 15, 2025.
- Shareholder proposals under Rule 14a-8 must be received by the company secretary by March 29, 2025.
- Proposals under Quebec Business Corporations Act and company by-laws due by April 15, 2025.
- Universal proxy rule notice for director nominations must be provided by April 11, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1408443/000110465925025547/0001104659-25-025547-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1408443/000110465925025547/tm259776d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-025547

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer